Cargando…
AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report
BACKGROUND: α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the brain and may be targeted by autoantibodies, leading to autoimmune synaptic encephalitis (AE). AE can be associated with other autoimmune dis...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999510/ https://www.ncbi.nlm.nih.gov/pubmed/36899302 http://dx.doi.org/10.1186/s12883-023-03129-2 |
_version_ | 1784903674235977728 |
---|---|
author | Schäfer, Jakob Christensen, Peter Brøgger Jensen, Kimmo |
author_facet | Schäfer, Jakob Christensen, Peter Brøgger Jensen, Kimmo |
author_sort | Schäfer, Jakob |
collection | PubMed |
description | BACKGROUND: α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the brain and may be targeted by autoantibodies, leading to autoimmune synaptic encephalitis (AE). AE can be associated with other autoimmune diseases. However, the cooccurrence of anti-AMPA and NMDA receptor AE together with myasthenia gravis (MG) is unusual. CASE PRESENTATION: A 24-year-old previously healthy male presented with seronegative ocular MG, the diagnosis of which was supported by single-fiber electrophysiology findings. Three months later, he developed AE, initially being positive for AMPA receptor antibodies and subsequently for NMDA receptor antibodies. No underlying malignancy was found. In response to aggressive immunosuppressive treatment, he recovered (modified Rankin Scale (mRS) score change from 5 to 1). Despite some cognitive problems at the 1-year follow-up, which were not revealed using the mRS, he was able to return to his studies. CONCLUSIONS: AE may coexist with other autoimmune disorders. Patients with seronegative MG, including ocular MG, may develop autoimmune encephalitis with more than one cell-surface antibody. |
format | Online Article Text |
id | pubmed-9999510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99995102023-03-11 AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report Schäfer, Jakob Christensen, Peter Brøgger Jensen, Kimmo BMC Neurol Case Report BACKGROUND: α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the brain and may be targeted by autoantibodies, leading to autoimmune synaptic encephalitis (AE). AE can be associated with other autoimmune diseases. However, the cooccurrence of anti-AMPA and NMDA receptor AE together with myasthenia gravis (MG) is unusual. CASE PRESENTATION: A 24-year-old previously healthy male presented with seronegative ocular MG, the diagnosis of which was supported by single-fiber electrophysiology findings. Three months later, he developed AE, initially being positive for AMPA receptor antibodies and subsequently for NMDA receptor antibodies. No underlying malignancy was found. In response to aggressive immunosuppressive treatment, he recovered (modified Rankin Scale (mRS) score change from 5 to 1). Despite some cognitive problems at the 1-year follow-up, which were not revealed using the mRS, he was able to return to his studies. CONCLUSIONS: AE may coexist with other autoimmune disorders. Patients with seronegative MG, including ocular MG, may develop autoimmune encephalitis with more than one cell-surface antibody. BioMed Central 2023-03-10 /pmc/articles/PMC9999510/ /pubmed/36899302 http://dx.doi.org/10.1186/s12883-023-03129-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Schäfer, Jakob Christensen, Peter Brøgger Jensen, Kimmo AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
title | AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
title_full | AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
title_fullStr | AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
title_full_unstemmed | AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
title_short | AMPA and NMDA receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
title_sort | ampa and nmda receptor antibody autoimmune encephalitis preceded by ocular myasthenia gravis: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999510/ https://www.ncbi.nlm.nih.gov/pubmed/36899302 http://dx.doi.org/10.1186/s12883-023-03129-2 |
work_keys_str_mv | AT schaferjakob ampaandnmdareceptorantibodyautoimmuneencephalitisprecededbyocularmyastheniagravisacasereport AT christensenpeterbrøgger ampaandnmdareceptorantibodyautoimmuneencephalitisprecededbyocularmyastheniagravisacasereport AT jensenkimmo ampaandnmdareceptorantibodyautoimmuneencephalitisprecededbyocularmyastheniagravisacasereport |